[1]
Paller, A., Cork, M. , Hong, C.- ho ., Soong, W., Schneider, S., Lo, H., Pedersen, L.R.M. , Vacko, E. and Wollenberg, A. 2024. Laboratory Parameters in Adolescent Patients Aged 12–17 with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52: Results from the Phase 3 ECZTRA 6 Trial. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s323. DOI:https://doi.org/10.25251/skin.8.supp.323.